Medication info
Januvia 50 mg (Sitagliptin Phosphate Hydrate)

Januvia 50 mg (Sitagliptin Phosphate Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Phosphate Hydrate›64.25mg / 1 tablet
Manufacturer / importer
White Life Sciences Co., Ltd.
Appearance
A light orange, round, bi-convex, film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202400182 · Approved 2024.01.24 · Insurance code 625202340

Summary

Main use
Improves blood glucose control in type 2 diabetes
Who takes it
Adults
Adult dose
For monotherapy or combination therapy, administer 100 mg once daily; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dose adjustment according to renal function is required, evaluation of renal function is recommended before treatment with this medicine and periodically thereafter. 1. No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. For patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. 4. For patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This medicine may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
White Life Sciences Co., Ltd.

Efficacy & effects

Improves blood glucose control in type 2 diabetes

View approved original text

This drug is used as an adjunct to help control blood glucose levels in patients with type 2 diabetes. It can be administered alone or in combination with other medications alongside dietary and exercise regimens. It helps effectively manage blood glucose levels to improve diabetes symptoms, and is thus used for blood glucose control in patients with type 2 diabetes.

How to take

Adult dose

For monotherapy or combination therapy, administer 100 mg once daily; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When administered in combination with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dose adjustment according to renal function is required, evaluation of renal function is recommended before treatment with this medicine and periodically thereafter. 1. No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. For patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2), administer 50 mg once daily. 4. For patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2), administer 25 mg once daily. This medicine may be administered regardless of the timing of dialysis.

Precautions

This drug may cause severe allergic reactions after administration, so if any allergy symptoms or skin abnormalities occur, it should be discontinued immediately and a physician should be consulted. Symptoms of pancreatitis may develop while taking this medication; therefore, if symptoms such as abdominal pain, nausea, or vomiting occur, promptly inform a healthcare provider. This drug should not be used in patients with type 1 diabetes or diabetic ketoacidosis, and should also not be administered in cases of hypersensitivity to this medication. Patients with impaired kidney function may require dosage adjustments for this medication, so regular kidney function tests should be conducted and it should be taken according to a physician's instructions. Since this drug may cause hypoglycemia when used alone or in combination with other diabetes medications, symptoms of hypoglycemia should be closely monitored and blood glucose should be measured frequently if necessary. While taking this drug, side effects such as headaches, upper respiratory infections, nasopharyngitis, and diarrhea may occur, and if abnormal symptoms persist, consult a physician. In cases of severe joint pain or blistering of the skin, this medication should be discontinued immediately and a healthcare provider should be consulted. It is best for pregnant or breastfeeding women to avoid this medication, and its safety has not been established in children under 18 years old. Elderly patients may have a risk of declining kidney function, so dosage adjustments and regular kidney function tests are necessary. In case of overdose, visit a medical institution immediately for appropriate treatment, as this drug can be partially removed through hemodialysis.

Side effects

  • Severe hypersensitivity reactions
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory tract infections
  • nasopharyngitis
  • headache
  • diarrhea
Show 31 more
  • abdominal pain
  • nausea
  • peripheral edema
  • constipation
  • vomiting
  • severe arthralgia with disability
  • vesiculobullous pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • pneumonia
  • diabetic complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased serum triglycerides
  • gastritis
  • increased low-density lipoprotein
  • hyperglycemia
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture, and it is best kept at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain its effectiveness and ensure safe use.

Appearance and packaging

Appearance

A light orange, round, bi-convex, film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.